Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021

 

Upgrades

  • According to Odeon Capital, the prior rating for Wells Fargo & Co WFC was changed from Hold to Buy. In the third quarter, Wells Fargo showed an EPS of $1.17, compared to $0.42 from the year-ago quarter. The current stock performance of Wells Fargo shows a 52-week-high of $52.56 and a 52-week-low of $27.28. Moreover, at the end of the last trading period, the closing price was at $48.43.
  • For HeadHunter Group PLC HHR, UBS upgraded the previous rating of Neutral to Buy. In the third quarter, HeadHunter Group showed an EPS of $0.54, compared to $0.20 from the year-ago quarter. The current stock performance of HeadHunter Group shows a 52-week-high of $68.18 and a 52-week-low of $24.25. Moreover, at the end of the last trading period, the closing price was at $51.70.
  • According to Stephens & Co., the prior rating for Truist Financial Corp TFC was changed from Equal-Weight to Overweight. Truist Financial earned $1.42 in the third quarter, compared to $0.97 in the year-ago quarter. At the moment, the stock has a 52-week-high of $65.42 and a 52-week-low of $45.44. Truist Financial closed at $60.08 at the end of the last trading period.
  • According to Citigroup, the prior rating for TJX Companies Inc TJX was changed from Neutral to Buy. TJX Companies earned $0.84 in the third quarter, compared to $0.71 in the year-ago quarter. At the moment, the stock has a 52-week-high of $76.94 and a 52-week-low of $61.15. TJX Companies closed at $69.36 at the end of the last trading period.
  • Citigroup upgraded the previous rating for Burlington Stores Inc BURL from Neutral to Buy. Burlington Stores earned $1.36 in the third quarter, compared to $0.29 in the year-ago quarter. At the moment, the stock has a 52-week-high of $357.34 and a 52-week-low of $217.38. Burlington Stores closed at $283.85 at the end of the last trading period.
  • According to Truist Securities, the prior rating for MGP Ingredients Inc MGPI was changed from Hold to Buy. In the third quarter, MGP Ingredients showed an EPS of $1.09, compared to $0.61 from the year-ago quarter. The stock has a 52-week-high of $79.52 and a 52-week-low of $42.42. At the end of the last trading period, MGP Ingredients closed at $73.51.
  • For Copa Holdings SA CPA, Raymond James upgraded the previous rating of Outperform to Strong Buy. For the third quarter, Copa Holdings had an EPS of $0.70, compared to year-ago quarter EPS of $2.86. At the moment, the stock has a 52-week-high of $94.91 and a 52-week-low of $64.66. Copa Holdings closed at $71.77 at the end of the last trading period.
  • Morgan Stanley upgraded the previous rating for Adagio Therapeutics Inc ADGI from Equal-Weight to Overweight.
  • For Surgery Partners Inc SGRY, Stifel upgraded the previous rating of Hold to Buy. For the third quarter, Surgery Partners had an EPS of $0.05, compared to year-ago quarter EPS of $0.53. At the moment, the stock has a 52-week-high of $69.58 and a 52-week-low of $24.20. Surgery Partners closed at $43.74 at the end of the last trading period.
  • For argenx SE ARGX, Piper Sandler upgraded the previous rating of Neutral to Overweight. In the third quarter, argenx showed an EPS of $4.40, compared to $3.96 from the year-ago quarter. The current stock performance of argenx shows a 52-week-high of $382.15 and a 52-week-low of $248.21. Moreover, at the end of the last trading period, the closing price was at $276.10.
  • Raymond James upgraded the previous rating for Bumble Inc BMBL from Market Perform to Outperform. For the third quarter, Bumble had an EPS of $0.06, compared to year-ago quarter EPS of $0.01. The current stock performance of Bumble shows a 52-week-high of $84.80 and a 52-week-low of $33.29. Moreover, at the end of the last trading period, the closing price was at $33.83.
  • For Hyatt Hotels Corp H, JP Morgan upgraded the previous rating of Neutral to Overweight. In the third quarter, Hyatt Hotels showed an EPS of $2.31, compared to $1.48 from the year-ago quarter. The current stock performance of Hyatt Hotels shows a 52-week-high of $94.92 and a 52-week-low of $65.44. Moreover, at the end of the last trading period, the closing price was at $78.13.

See all analyst ratings upgrades.

 

Downgrades

  • For Apellis Pharmaceuticals Inc APLS, Roth Capital downgraded the previous rating of Buy to Neutral. Apellis Pharmaceuticals earned $1.57 in the third quarter, compared to $1.79 in the year-ago quarter. The stock has a 52-week-high of $73.00 and a 52-week-low of $27.50. At the end of the last trading period, Apellis Pharmaceuticals closed at $43.54.
  • For Jumia Technologies AG JMIA, Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. At the moment, the stock has a 52-week-high of $69.89 and a 52-week-low of $11.96. Jumia Technologies closed at $13.64 at the end of the last trading period.
  • For Saia Inc SAIA, Deutsche Bank downgraded the previous rating of Buy to Hold. In the third quarter, Saia showed an EPS of $2.86, compared to $1.56 from the year-ago quarter. The stock has a 52-week-high of $365.50 and a 52-week-low of $171.00. At the end of the last trading period, Saia closed at $335.83.
  • For U.S. Bancorp USB, Stephens & Co. downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, U.S. Bancorp showed an EPS of $1.30, compared to $0.99 from the year-ago quarter. The current stock performance of U.S. Bancorp shows a 52-week-high of $63.01 and a 52-week-low of $42.47. Moreover, at the end of the last trading period, the closing price was at $57.50.
  • According to Deutsche Bank, the prior rating for Canadian Pacific Railway Ltd CP was changed from Buy to Hold. For the third quarter, Canadian Pacific Railway had an EPS of $0.70, compared to year-ago quarter EPS of $0.62. At the moment, the stock has a 52-week-high of $404.43 and a 52-week-low of $64.37. Canadian Pacific Railway closed at $71.31 at the end of the last trading period.
  • Deutsche Bank downgraded the previous rating for United Parcel Service Inc UPS from Buy to Hold. For the third quarter, United Parcel Service had an EPS of $2.71, compared to year-ago quarter EPS of $2.28. The current stock performance of United Parcel Service shows a 52-week-high of $220.24 and a 52-week-low of $154.76. Moreover, at the end of the last trading period, the closing price was at $205.30.
  • For Beacon Roofing Supply Inc BECN, Truist Securities downgraded the previous rating of Buy to Hold. For the fourth quarter, Beacon Roofing Supply had an EPS of $1.78, compared to year-ago quarter EPS of $1.30. The current stock performance of Beacon Roofing Supply shows a 52-week-high of $60.93 and a 52-week-low of $35.86. Moreover, at the end of the last trading period, the closing price was at $53.77.
  • According to Wells Fargo, the prior rating for Greif Inc GEF was changed from Overweight to Equal-Weight. In the third quarter, Greif showed an EPS of $1.93, compared to $0.85 from the year-ago quarter. The current stock performance of Greif shows a 52-week-high of $72.00 and a 52-week-low of $44.16. Moreover, at the end of the last trading period, the closing price was at $67.66.
  • According to Citigroup, the prior rating for Merck & Co Inc MRK was changed from Buy to Neutral. For the third quarter, Merck & Co had an EPS of $1.75, compared to year-ago quarter EPS of $1.74. The current stock performance of Merck & Co shows a 52-week-high of $91.40 and a 52-week-low of $15.32. Moreover, at the end of the last trading period, the closing price was at $79.16.
  • Piper Sandler downgraded the previous rating for Hudson Pacific Properties Inc HPP from Overweight to Neutral. For the third quarter, Hudson Pacific Properties had an EPS of $0.50, compared to year-ago quarter EPS of $0.43. The current stock performance of Hudson Pacific Properties shows a 52-week-high of $30.35 and a 52-week-low of $22.75. Moreover, at the end of the last trading period, the closing price was at $25.33.
  • According to Jefferies, the prior rating for CyrusOne Inc CONE was changed from Buy to Hold. In the third quarter, CyrusOne showed an EPS of $1.02, compared to $0.96 from the year-ago quarter. The current stock performance of CyrusOne shows a 52-week-high of $89.92 and a 52-week-low of $61.64. Moreover, at the end of the last trading period, the closing price was at $89.24.

See all analyst ratings downgrades.

 

Initiations

  • EF Hutton initiated coverage on ComSovereign Holding Corp COMS with a Buy rating. The price target for ComSovereign Holding is set to $2.10. At the moment, the stock has a 52-week-high of $5.78 and a 52-week-low of $1.01. ComSovereign Holding closed at $1.15 at the end of the last trading period.
  • William Blair initiated coverage on Allbirds Inc BIRD with an Outperform rating.
  • With an Overweight rating, Stephens & Co. initiated coverage on Cadre Holdings Inc CDRE. The price target seems to have been set at $23.00 for Cadre Hldgs.
  • With an Outperform rating, Oppenheimer initiated coverage on Nerdwallet Inc NRDS. The price target seems to have been set at $30.00 for Nerdwallet.
  • Maxim Group initiated coverage on Worksport Ltd WKSP with a Buy rating. The price target for Worksport is set to $8.00. In the third quarter, Worksport showed an EPS of $0.15, compared to $0.21 from the year-ago quarter. The current stock performance of Worksport shows a 52-week-high of $9.09 and a 52-week-low of $0.12. Moreover, at the end of the last trading period, the closing price was at $3.86.
  • With a Buy rating, Maxim Group initiated coverage on Acurx Pharmaceuticals Inc ACXP. The price target seems to have been set at $12.00 for Acurx Pharmaceuticals. For the third quarter, Acurx Pharmaceuticals had an EPS of $0.46, compared to year-ago quarter EPS of $0.21. At the moment, the stock has a 52-week-high of $8.74 and a 52-week-low of $3.71. Acurx Pharmaceuticals closed at $4.89 at the end of the last trading period.
  • With a Equal-Weight rating, Morgan Stanley initiated coverage on Nerdwallet Inc NRDS. The price target seems to have been set at $24.00 for Nerdwallet.
  • Morgan Stanley initiated coverage on Arhaus Inc ARHS with a Equal-Weight rating. The price target for Arhaus is set to $12.00.
  • For Evotec SE EVO, Cowen & Co. initiated coverage, by setting the current rating at Outperform.
  • With a Hold rating, Stifel initiated coverage on Cadre Holdings Inc CDRE. The price target seems to have been set at $20.00 for Cadre Hldgs.
  • With an Outperform rating, JMP Securities initiated coverage on iBio Inc IBIO. The price target seems to have been set at $1.50 for iBio. In the first quarter, iBio showed an EPS of $0.04, compared to $0.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.83 and a 52-week-low of $0.56. iBio closed at $0.66 at the end of the last trading period.
  • Truist Securities initiated coverage on Nerdwallet Inc NRDS with a Buy rating. The price target for Nerdwallet is set to $30.00.
  • With a Buy rating, BTIG initiated coverage on Freeline Therapeutics Holdings PLC FRLN. The price target seems to have been set at $10.00 for Freeline Therapeutics. At the moment, the stock has a 52-week-high of $18.88 and a 52-week-low of $2.15. Freeline Therapeutics closed at $2.31 at the end of the last trading period.
  • With a Buy rating, BTIG initiated coverage on MDxHealth SA MDXH. The price target seems to have been set at $15.00 for MDxHealth.
  • Atlantic Equities initiated coverage on Allegion PLC ALLE with an Overweight rating. The price target for Allegion is set to $155.00. Allegion earned $1.56 in the third quarter, compared to $1.67 in the year-ago quarter. The current stock performance of Allegion shows a 52-week-high of $148.69 and a 52-week-low of $106.52. Moreover, at the end of the last trading period, the closing price was at $129.37.
  • B. Riley Securities initiated coverage on Cadre Holdings Inc CDRE with a Buy rating. The price target for Cadre Hldgs is set to $26.00.
  • Needham initiated coverage on Inozyme Pharma Inc INZY with a Buy rating. The price target for Inozyme Pharma is set to $23.00. In the third quarter, Inozyme Pharma showed an EPS of $0.60, compared to $1.55 from the year-ago quarter. The current stock performance of Inozyme Pharma shows a 52-week-high of $29.46 and a 52-week-low of $7.66. Moreover, at the end of the last trading period, the closing price was at $8.00.
  • With a Neutral rating, Piper Sandler initiated coverage on Affirm Holdings Inc AFRM. The price target seems to have been set at $127.00 for Affirm Holdings. The stock has a 52-week-high of $176.65 and a 52-week-low of $46.50. At the end of the last trading period, Affirm Holdings closed at $136.98.
  • With a Neutral rating, Piper Sandler initiated coverage on Synchrony Financial SYF. The price target seems to have been set at $52.00 for Synchrony Finl. Synchrony Finl earned $2.00 in the third quarter, compared to $0.63 in the year-ago quarter. The current stock performance of Synchrony Finl shows a 52-week-high of $52.49 and a 52-week-low of $30.43. Moreover, at the end of the last trading period, the closing price was at $47.68.

See all analyst ratings initiations.

Posted In: BZI-RatingsUpgradesDowngradesInitiationIntraday UpdateAnalyst Ratings